Sino Biopharmaceutical Stock Falls 2.3% in Hong Kong, Underperforms Competitors

Dow Jones10-02

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Sino Biopharmaceutical Ltd. slid 2.3% to 5.58 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 2.6% to 23972.29.

The stock's fall snapped a two-day winning streak.

Sino Biopharmaceutical Ltd. closed 35% short of its 52-week high of HK$8.54, which the company achieved Oct. 8.

The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.4% and Amgen Inc. remained unchanged.

Trading volume totaled 35.3 million shares, compared to the 50-day average of 80.7 million shares.

Data source: Dow Jones Market Data, FactSet

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment